Cottage Street Advisors LLC Biogen Inc. Transaction History

Cottage Street Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 08, 2020	SELL	$264.77 - $305.71 $317,724 - $366,852	-1,200 Closed	0 $0
Q2 2020 Jul 09, 2020	SELL	$258.66 - $342.55 $77,598 - $102,765	-300 Reduced 20.0%	1,200 $321,000
Q1 2020 Apr 29, 2020	SELL	$268.85 - $341.04 $188,195 - $238,728	-700 Reduced 31.82%	1,500 $475,000
Q4 2019 Jan 31, 2020	BUY	$220.06 - $304.07 $154,042 - $212,849	700 Added 46.67%	2,200 $653,000
Q3 2019 Oct 24, 2019	BUY	$217.44 - $243.88 $326,160 - $365,820	1,500 New	1,500 $349,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cottage Street Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cottage Street Advisors LLC with notifications on news.